$12.22 -0.14 (-1.13%) OncoMed Pharmaceuticals Inc - NASDAQ

Jul. 28, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 12.22
Trade Time: Jul 28 04:00 PM Eastern Daylight Time
Change: -0.14 (-1.13%)
Prev Close: 12.36
Open: 12.39
Bid: 12.20
Ask: 12.22
  1. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD | Jan. 11, 2016 | 19:05PM EST
  2. Celgene Numbers Disappoint; New CEO Announced

    IBD | Jan. 11, 2016 | 13:59PM EST
  3. Benzinga's Volume Movers

    Benzinga | Dec. 24, 2015 | 10:33AM EST
  4. OncoMed Presents Positive Immuno-Oncology Data for Combined Blockade of DLL4, VEGF and PD1 at SITC Conference

    Benzinga | Nov. 7, 2015 | 17:23PM EST
  5. OncoMed Reports Presentation of Phase 1b Trial for Tarextumab in Small Cell Lung Cancer at ASCO

    Benzinga | Jun. 1, 2015 | 09:09AM EST
  6. Oncomed Offers Data from Phase 1a Trial of OMP-52M51 in Oral Plenary Session

    Benzinga | Nov. 19, 2014 | 07:53AM EST
  7. 3 Companies Investing In Stem Cell Research

    Benzinga | Sep. 14, 2014 | 16:34PM EST
  8. Events for the Week of Sept. 8-12

    Benzinga | Sep. 10, 2014 | 14:34PM EST
  9. Mid-Afternoon Market Update: Markets Reverse Early Loses; Oil Continues To Rise On Overseas Worry

    Benzinga | Jun. 13, 2014 | 15:36PM EST
  10. Mid-Morning Market Update: Markets Mostly Flat; Priceline To Acquire OpenTable For $103/Share

    Benzinga | Jun. 13, 2014 | 10:25AM EST
  11. Morning Market Losers

    Benzinga | Jun. 13, 2014 | 09:44AM EST
  12. OncoMed Presents Data on Multiple Anti-Cancer Stem Cell Programs at American Association for Cancer Research Annual Meeting

    Benzinga | Apr. 8, 2014 | 08:39AM EST
  13. OncoMed Pharmaceuticals Commences Third Phase 1b Clinical Trial for OMP-54F28 (Fzd8-Fc) With Carboplatin and Paclitaxel in Ovarian Cancer

    Benzinga | Feb. 20, 2014 | 08:33AM EST
  14. UPDATE: OncoMed Pharmaceuticals Initiates Second Phase 1b Clinical Trial for OMP-54F28 (Fzd8-Fc) With Sorafenib (Nexavar(R)) in Hepatocellular Cancer

    Benzinga | Feb. 18, 2014 | 08:30AM EST
  15. Benzinga's Top Initiations

    Benzinga | Feb. 11, 2014 | 08:03AM EST
Trading Center